Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR) Based Tissue Engineering in the Treatment of Multiple Sclerosis

NCT01220830 is registered in ClinicalTrials.gov with The Centre for Advanced Research & Development, India as lead sponsor.

NCT NCT01220830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR) Based Tissue Engineering in the Treatment of Multiple Sclerosis
Lead sponsor
The Centre for Advanced Research & Development, India
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2010
Completion date
December 31, 2011
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis